Skip to content
DataLookout
Menu

NCT06891794

Use of Cervical Cap and Menstrual Disc for Application of Topical Anesthetic Prior to IUD Insertion

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 18 words Show 5 more changesShow less
    • Trial completed
    • Enrollment target: estimated 24 to confirmed 26
    • Primary and study completion dates changed from estimate of Apr 2026 to May 8, 2026
    • Secondary endpoints: details revised at 5 of 7 entries
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2025 to Aug 4, 2025
    • Secondary endpoints: details revised at 3 of 7 entries
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Successful Placement
Timeframe: Immediately after IUD placement procedure
Satisfaction with pain control
Timeframe: Immediately after IUD placement procedure

Secondary (7)

Ease of cap/disc placement
Protocol deviations
Ease of IUD placement
Procedure complications
Typical menstrual pain
Show 2 moreShow less
Pain during IUD placement procedure
Acceptability of pain mangement

Arms and interventions

Menstrual discExperimental

Participants will be provided with a menstrual disc filled with 5mg of 2.5% prilocaine-2.5% lidocaine cream and manufacturer instructions for placement. Study personnel will leave the room, and participants will undress and attempt to place the disc. The provider will return to the room, make sure the disc is correctly placed, and set a seven minute timer. After the seven minute timer, participants will self-remove the disc or the clinician will remove it and place the intrauterine device (IUD) according to manufacturer technique.

Cervical capExperimental

Participants will be provided with a cervical cap filled with 5mg of 2.5% prilocaine-2.5% lidocaine cream and manufacturer instructions for placement. Study personnel will leave the room, and participants will undress and attempt to place the cap. The provider will return to the room, make sure the cap is correctly placed, and set a seven minute timer. After the seven minute timer, participants will self-remove the cap or the clinician will remove it and place the intrauterine device (IUD) according to manufacturer technique.

Combination products: Menstrual disc with EMLA cream, Cervical cap with EMLA cream

Sites

1 site in 1 country

  • Oregon Health & Science UniversityPortland, Oregon, United States